Insider transaction filing: MA — C4 Therapeutics, Inc.
Why now
Thesis: Form 4 alone gives no direction without detail
Catalyst to watch: Disclosure of transaction type and size
Main risk: Insider sale may signal weak conviction
Why it matters
Form 4 discloses insider activity but the filing alone gives no direction without transaction detail.
Details
C4 Therapeutics, Inc. filed SEC Form 4 on 2026-09-21.
Related assets & topics
Mastercard · MASources
- sec4 · sec.gov · 2026-09-21 00:00 UTC